Literature DB >> 19228650

Association of polymorphisms in interferon regulatory factor 5 gene with rheumatoid arthritis: a metaanalysis.

Seung Woo Han1, Won Ki Lee, Ki Tae Kwon, Byung Ki Lee, Eon Jeong Nam, Gun Woo Kim.   

Abstract

OBJECTIVE: We investigated potential associations between rheumatoid arthritis (RA) and interferon regulatory factor 5 (IRF5) polymorphisms in a metaanalysis.
METHODS: This metaanalysis included 5 case-control studies, which provided a total of 6582 RA cases and 5375 controls. Odds ratios (OR) were employed to evaluate the risk of RA according to the 4 single-nucleotide polymorphisms (SNP) in IRF5 (rs729302, rs2004640, rs752637, and rs2280714) and data were analyzed in respect to association between alleles.
RESULTS: Among 4 candidate SNP, rs729302, rs2004640, and rs2280714 were statistically significant; both allele C of rs729302 and allele G of rs2004640 within the promoter region of IRF5 were associated with a protective effect [random-effects (RE) OR 0.889, 95% confidence interval (CI) 0.803-0.977, p=0.015 for rs729302; and RE OR 0.905, 95% CI 0.848-0.965, p=0.002 for rs2004640]. Similar results were also obtained in T allele of rs2280714 in the 3'-untranslated region (RE OR 0.927, 95% CI 0.866-0.992, p=0.029). There was no evidence of publication bias from funnel-plot asymmetry and Egger's regression test.
CONCLUSION: Our metaanalysis supported the evidence of the significant role of IRF5 polymorphisms in RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228650     DOI: 10.3899/jrheum.081054

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

2.  Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap.

Authors:  Mai Tuyet Vuong; Iva Gunnarsson; Sigrid Lundberg; Elisabet Svenungsson; Lars Wramner; Anders Fernström; Ann-Christine Syvänen; Lieu Thi Do; Stefan H Jacobson; Leonid Padyukov
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

3.  Associations between interferon regulatory factor 5 polymorphisms and rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2012-10-18       Impact factor: 2.316

4.  A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis.

Authors:  Stefan Wieczorek; Julia U Holle; Stephanie Müller; Harald Fricke; Wolfgang L Gross; Jörg T Epplen
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

5.  Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data.

Authors:  Lorenzo Beretta; Alessandro Santaniello; Piet L C M van Riel; Marieke J H Coenen; Raffaella Scorza
Journal:  BMC Bioinformatics       Date:  2010-08-06       Impact factor: 3.169

6.  A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis.

Authors:  Hirofumi Nakaoka; Tailin Cui; Atsushi Tajima; Akira Oka; Shigeki Mitsunaga; Koichi Kashiwase; Yasuhiko Homma; Shinji Sato; Yasuo Suzuki; Hidetoshi Inoko; Ituro Inoue
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

7.  Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases.

Authors:  Hariklia Eleftherohorinou; Victoria Wright; Clive Hoggart; Anna-Liisa Hartikainen; Marjo-Riitta Jarvelin; David Balding; Lachlan Coin; Michael Levin
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

8.  Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.

Authors:  Marit Stockfelt; Anna-Carin Lundell; Merete Lund Hetland; Mikkel Østergaard; Till Uhlig; Marte Schrumpf Heiberg; Espen A Haavardsholm; Michael T Nurmohamed; Jon Lampa; Dan Nordström; Kim Hørslev Petersen; Bjorn Gudbjornsson; Gerdur Gröndal; Jonathan Aldridge; Kerstin Andersson; Kaj Blennow; Henrik Zetterberg; Ronald van Vollenhoven; Anna Rudin
Journal:  Arthritis Res Ther       Date:  2021-07-13       Impact factor: 5.156

9.  The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.

Authors:  F David Carmona; Jose-Ezequiel Martin; Lorenzo Beretta; Carmen P Simeón; Patricia E Carreira; José Luis Callejas; Mónica Fernández-Castro; Luis Sáez-Comet; Emma Beltrán; María Teresa Camps; María Victoria Egurbide; Paolo Airó; Raffaella Scorza; Claudio Lunardi; Nicolas Hunzelmann; Gabriela Riemekasten; Torsten Witte; Alexander Kreuter; Jörg H W Distler; Rajan Madhok; Paul Shiels; Jacob M van Laar; Carmen Fonseca; Christopher Denton; Ariane Herrick; Jane Worthington; Annemie J Schuerwegh; Madelon C Vonk; Alexandre E Voskuyl; Timothy R D J Radstake; Javier Martín
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Macrophages in synovial inflammation.

Authors:  Aisling Kennedy; Ursula Fearon; Douglas J Veale; Catherine Godson
Journal:  Front Immunol       Date:  2011-10-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.